CANAKINUMAB VS TRIAMCINOLONE ACETONIDE FOR TREATMENT OF ACUTE FLARES AND PREVENTION OF RECURRENT FLARES IN "DIFFICULT TO TREAT" GOUTY ARTHRITIS

被引：0
|
作者：
Schlesinger, N.
De Meulemeester, M. [1 ]
Shamim, T. [2 ]
Pikhlak, A. [3 ]
Arulmani, U. [4 ]
Richard, D. [4 ]
Murphy, V [4 ]
Sallstig, P. [4 ]
So, A. [5 ]
机构：
[1] UMDNJ, RWJMS, New Brunswick, NJ USA
[2] Heartland Clin Res, Omaha, NE USA
[3] MSUMD, Moscow, Russia
[4] Novartis, Basel, Switzerland
[5] CHU Vaudois, CH-1011 Lausanne, Switzerland
来源：
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY | 2010年 / 16卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S23 / S23
页数：1
相关论文
共 41 条
  • [21] Canakinumab relieves symptoms of acute flares and improves health-related quality of life in patients with difficult-to-treat Gouty Arthritis by suppressing inflammation: results of a randomized, dose-ranging study
    Schlesinger, Naomi
    De Meulemeester, Marc
    Pikhlak, Andrey
    Yucel, A. Eftal
    Richard, Dominik
    Murphy, Valda
    Arulmani, Udayasankar
    Sallstig, Peter
    So, Alexander
    ARTHRITIS RESEARCH & THERAPY, 2011, 13 (02)
  • [22] Canakinumab relieves symptoms of acute flares and improves health-related quality of life in patients with difficult-to-treat Gouty Arthritis by suppressing inflammation: results of a randomized, dose-ranging study
    Naomi Schlesinger
    Marc De Meulemeester
    Andrey Pikhlak
    A Eftal Yücel
    Dominik Richard
    Valda Murphy
    Udayasankar Arulmani
    Peter Sallstig
    Alexander So
    Arthritis Research & Therapy, 13
  • [23] LONG-TERM SAFETY AND EFFICACY OF CANAKINUMAB VS TRIAMCINOLONE ACETONIDE IN PATIENTS WITH FREQUENT ACUTE GOUTY ARTHRITIS ATTACKS WHO ARE CONTRAINDICATED, INTOLERANT OR UNRESPONSIVE TO NSAIDS AND/OR COLCHICINE
    Alten, R.
    Schlesinger, N.
    So, A.
    Schumacher, H. R.
    Bloch, M. T.
    Machein, U.
    Richard, D.
    Lheritier, K.
    Bardin, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 785 - 785
  • [24] Canakinumab Relieves Symptoms of Acute Flares and Improves Health-Related Quality Of Life (HRQoL) in Difficult-To-Treat Gouty Arthritis Patients by Suppressing Inflammation: Results of a Randomized, Dose-Ranging Study
    So, A.
    DeMeulenmeester, M.
    Yucel, E.
    Arulmani, U.
    Richard, D.
    Murphy, V.
    Sallstig, P.
    Schlesinger, N.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (02) : AB227 - AB227
  • [25] Canakinumab Reduces The Risk Of Acute Gouty Arthritis Flares During Initiation Of Allopurinol Therapy: Results Of A Double-blind, Randomised Study
    Schlesinger, N.
    Mysler, E.
    Lin, H.
    DeMeulenmeester, M.
    Rovensky, J.
    Arulmani, U.
    Balfour, A.
    Krammer, G.
    Sallstig, P.
    So, A.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (02) : AB227 - AB227
  • [26] Control of flares and relief of urate burden with canakinumab and targeted urate-lowering therapy in tophaceous gouty arthritis
    Fanouriakis, Antonis
    Karantanas, Apostolos
    Fragouli, Eleni
    Repa, Argyro
    Sidiropoulos, Prodromos
    RHEUMATOLOGY, 2014, 53 (04) : 764 - 766
  • [27] Colchicine for prophylaxis of acute flares when initiating allopurinol for chronic gouty arthritis
    Borstad, GC
    Bryant, LR
    Abel, MP
    Scroggie, DA
    Harris, MD
    Alloway, JA
    JOURNAL OF RHEUMATOLOGY, 2004, 31 (12) : 2429 - 2432
  • [28] Efficacy of Canakinumab Versus Triamcinolone Acetonide According to Multiple Gouty Arthritis-Related Health Outcomes Measures.
    Gnanasakthy, Ari
    Sarkin, Andrew
    Lale, Rachel
    Choi, Kyle
    Hirsch, Jan D.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S62 - S62
  • [29] Defining a Role for Canakinumab and IL-1 inhibition in Difficult-to-Treat Gouty Arthritis Foreword
    Bardin, Thomas
    van de Laar, Martinus A. F. J.
    JOINT BONE SPINE, 2015, 82 : ES1 - ES1
  • [30] The Way Forward: Practical Clinical Considerations for the Use of Canakinumab in Patients With Difficult-to-Treat Gouty Arthritis
    Bardin, Thomas
    van de Laar, Martinus A. F. J.
    JOINT BONE SPINE, 2015, 82 : ES30 - ES32
12345